HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pappas, M. G. Articles by Hockmeyer, W. T. Search for Related Content PubMed PubMed Citation Articles by Pappas, M. G. Articles by Hockmeyer, W. T.

Standardization of the Dot Enzyme-Linked Immunosorbent Assay (Dot-ELISA) for Human Visceral Leishmaniasis^*

The Dot-ELISA, a rapid, visually read micro enzyme immunoassay for visceral leishmaniasis utilizing minute volumes of antigen "dotted" on nitrocellulose filter discs and precipitable chromogenic substrate, was analyzed under a variety of experimental parameters. Raising assay incubation temperatures from 23°C to 28°C resulted in titer increases in three of five leishmaniasis patient sera; at 37°C, all five patient sera and one of five normal human sera showed titer increases. The amount of antigen used could be reduced 50% by incubating patient serum overnight at 4°C. Antigen discs stored at -20°C were optimally reactive with leishmaniasis sera over a 270-day period. Antigen discs stored at 4°C and 23°C showed reproducible titer decreases at 90 days. Aging either peroxidase-conjugated antibody or substrate for up to 28 days at 4°C did not adversely affect titers of positive and negative control sera and reagent controls. Activated substrate stored at 23°C was optimally reactive in the assay for at least 24 hours. No changes in titers of positive and negative control sera or nonspecific reactions in reagent controls occurred when using different brands of microtiter plates. The long shelf lives and stabilities of Dot-ELISA antigen and reagents indicate this test should prove useful both in the laboratory and in the field.

Accepted for publication April 10, 1984.

^* The views of the authors do not purport to reflect the position of the Department of the Army or the Department of Defense (para. 4-3, AR 360-5).

A preliminary report of this work was presented at the joint meeting of the American Society of Tropical Medicine and Hygiene and American Association of Parasitologists in December 1983, San Antonio, Texas.

Address reprint requests and correspondence to: CPT Michael G. Pappas, Ph.D., Department of Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.